Prices as of 2026/10/30 close
Company comparison · Confectionery Makers
Glico is the bigger company, with revenue of ¥361.4B — 2.6x Kameda Seika's ¥138.1B.
Kameda Seika earns more on each yen of sales, with an operating margin of 5.5% — 3.0 points above Glico (2.4%).
Revenue growth in the latest results: Kameda Seika +33.7%, Glico +9.1%. For next year, Glico guides for the fastest operating profit growth (+60.3%).
Glico pays more on average — ¥8.60M against ¥5.69M at Kameda Seika.
Over the past year the shares moved Kameda Seika +8.1%, Glico +2.8%.
Head-to-head wins17 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
Glico aheadGlico 2 : Kameda Seika 1
Revenue: Glico ¥361.4B / Kameda Seika ¥138.1B
ProfitabilityInvestors
Kameda Seika aheadGlico 1 : Kameda Seika 3
Operating margin: Glico 2.4% / Kameda Seika 5.5%
GrowthInvestors
EvenGlico 2 : Kameda Seika 2
Revenue growth (YoY): Glico +9.1% / Kameda Seika +33.7%
Stock & balance sheetInvestors
Kameda Seika aheadGlico 1 : Kameda Seika 2
Share price, 1 year: Glico +2.8% / Kameda Seika +8.1%
Pay & workforceJob seekers
Glico aheadGlico 2 : Kameda Seika 1
Average salary: Glico ¥8.60M / Kameda Seika ¥5.69M
| Metric | Glico | Kameda Seika | Gap |
|---|---|---|---|
| Revenue | ◎¥361.4B | ¥138.1B | 2.6x |
| Operating profit | ◎¥8.7B | ¥7.5B | 1.2x |
| Net income | ¥5.0B | ◎¥24.6B | 4.9x |
| Metric | Glico | Kameda Seika | Gap |
|---|---|---|---|
| Operating margin | 2.4% | ◎5.5% | 3.0pt |
| Net margin | 1.4% | ◎17.9% | 16.5pt |
| ROE | 1.8% | ◎27.6% | 25.8pt |
| Revenue per employee | ◎¥248M | ¥98M | 2.5x |
| Metric | Glico | Kameda Seika | Gap |
|---|---|---|---|
| Revenue growth (YoY) | +9.1% | ◎+33.7% | 24.6pt |
| Operating profit growth (YoY) | −21.0% | ◎+36.9% | 57.9pt |
| Guidance: revenue growthnext FY plan | ◎+5.1% | +3.6% | 1.6pt |
| Guidance: op. profit growthnext FY plan | ◎+60.3% | +10.3% | 50.0pt |
| Metric | Glico | Kameda Seika | Gap |
|---|---|---|---|
| Share price, 1 year | +2.8% | ◎+8.1% | 5.3pt |
| Share price, 3 months | −3.7% | ◎+6.7% | 10.4pt |
| P/E (trailing)lower = cheaper | 63.5x | 3.5x | |
| Equity ratio | ◎70.7% | 56.6% | 14.1pt |
| Share price (close) | ¥5,028 | ¥1,377 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | Glico | Kameda Seika | Gap |
|---|---|---|---|
| Average salary | ◎¥8.60M | ¥5.69M | ¥2.91M |
| Starting salary (monthly) | ◎¥265,500 | ¥250,200 | ¥15,300 |
| Average tenure | 13.4 yrs | ◎17.8 yrs | 4.4 |
| Average age | 43.7 | 41.0 | 2.7 |
| Employees | 1,456 | 1,404 | 1.0x |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥5,028+2.8% (1Y)
Glico +2.8% over 1Y. Compared: Kameda Seika +8.1%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
Glico2 segments
Kameda Seika4 segments
AAverage annual salary from the securities filings: Glico ¥8.60M, Kameda Seika ¥5.69M. Glico pays the most. Averages also depend on staff age and job mix, so check the average age too (Glico 43.7, Kameda Seika 41.0).
ARevenue in the latest results: Glico ¥361.4B, Kameda Seika ¥138.1B. Glico is the bigger company, with revenue of ¥361.4B — 2.6x Kameda Seika's ¥138.1B.
AOperating margins: Kameda Seika 5.5%, Glico 2.4%. Kameda Seika turns the highest share of sales into operating profit.
AShare price change over the past year (closing prices, for reference): Kameda Seika +8.1%, Glico +2.8%. Kameda Seika has risen the most.

Comparing 2 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.